LINK Medical appointed by OncoZenge to conduct European feasibility study ahead of Phase III trial
LINK Medical AS acquires clinical research company CRST Oy to strengthen its position in the Nordic countries
New CEO at LINK Medical
A Successful Collaboration results in End of Procedure (EOP) for the paediatric indication for Sedaconda (isoflurane)
First Patient Dosed in Phase II Clinical Trial of Lipisense®
Contact us and we will tell you more
Search the site
Search on LINK Medical